Dan Troy

Dan Troy

Chairman at
National Chamber Litigation Center
66 year
Health Technology
Consumer Services
Commercial Services

Profile

Daniel E.
Troy
is currently the Chairman at the National Chamber Litigation Center since 2008, the Secretary & Director at Human Genome Sciences, Inc. since 2012, the Director at NeuroRx, Inc. since 2018, and a Member of The American Law Institute.
Previously, he served as the Chairman-Administrative Law Section at the American Bar Association in 2007, Chairman of the Civil Justice Reform Group, Independent Director at NRX Pharmaceuticals, Inc. from 2021 to 2022, Chief Business & Administrative Officer at Valo Health, Inc., Senior Vice President & General Counsel at GSK Plc from 2008 to 2018, Chief Counsel at the US Food & Drug Administration, and Partner at Sidley Austin LLP from 2005 to 2008.
He also has a background in law, having studied at Columbia Law School and being a member of the Law Review and a Kent Scholar.
He completed his undergraduate studies at Cornell University.

Dan Troy active positions

CompaniesPositionStart
Director/Board Member 29/07/2012
National Chamber Litigation Center
Chairman 31/12/2007
Corporate Officer/Principal -
Director/Board Member 31/12/2017

Former positions of Dan Troy

CompaniesPositionEnd
NRX PHARMACEUTICALS, INC. Director/Board Member 17/07/2022
GSK PLC General Counsel 31/07/2018
Corporate Officer/Principal 31/12/2007
Corporate Officer/Principal 31/12/2006
Chief Administrative Officer -
See the detail of Dan Troy's experience

Training of Dan Troy

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

82

1st degree connections

13

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies13

Health Technology

Finance

Health Technology

Consumer Services

Commercial Services

Government

Consumer Services

National Chamber Litigation Center

Consumer Services

Health Technology

Commercial Services

Health Technology

- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!